Johan Garssen

This inventor holds 26 USPTO granted patents and 23 published patent applications, plus 8 CIPO patents and 35 EPO patents, primarily in Nutritional Immunology. Top assignee: N.v. Nutricia. Active years: 2011-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johan Garssen. Retrieved from https://idiyas.com/inventor/johan-garssen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 26 (Patent Applications = 23)

% Patents Active = 65.4

CIPO Patents = 8 (Patent Applications = 4)

EPO Patents = 35 (Patent Applications = 45)

Average Co-Inventor Count = 3.9

ph-index = 4

Forward Citations = 58(Granted Patents)

Location History:

Nieuwehein, NL (2013)
Nieuwegein, NL (2011 - 2017)
DA Nieuwegein, NL (2015 - 2017)
Utrecht, NL (2017 - 2024)

Company Filing History:

25 out of 273

N.v. Nutricia

patents

where one patent can have more than one assignee

Years Active: 2011-2026

Loading Chart...

Areas of Expertise:

Nutritional Composition

Immune System

Non-Digestible Oligosaccharides

Probiotics

Synbiotics

Gut Barrier Function

Oral Tolerance

Infant Nutrition

Immunoglobulins

Bifidobacterium

Mycotoxin Exposure

26 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12685768 - Nutritional composition for improving immune fitness (2026-07-21),

2. 12508273 - Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases (2025-12-30),

3. 12023347 - Composition with non-digestible oligosaccharides for attenuating nasal epithelial inflammation (2024-07-02),

4. 11389492 - Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptides in combination with probiotic (2022-07-19),

5. 11135290 - Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit (2021-10-05),

6. 11090321 - Mixture of non-digestible oligosaccharides for stimulating the immune system (2021-08-17),

7. 10588965 - Fucosyllactose as breast milk identical non-digestible oligosaccharide with new functional benefit (2020-03-17),

8. 10420784 - Mixture of non-digestible oligosaccharides for stimulating the immune system (2019-09-24),

9. 10124016 - Immune system stimulating nutrition (2018-11-13),

10. 10071125 - Nutritional composition with probiotics (2018-09-11),

11. 9974816 - Synbiotics combination for brain improvement (2018-05-22),

12. 9883692 - Nutrition with non-viable bifidobacterium and nondigestible oligosaccharide (2018-02-06),

13. 9782422 - Treatment of conditions associated with mycotoxin exposure (2017-10-10),

14. 9770460 - Non-digestible oligosaccharides for oral induction of tolerance against dietary proteins (2017-09-26),

15. 9566291 - Nutritional composition comprising indigestible oligosaccharides (2017-02-14),

Title: Johan Garssen - Innovative Inventor from Utrecht

Introduction: Johan Garssen is a renowned inventor hailing from Utrecht, Netherlands, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Johan Garssen holds several patents in the areas of biotechnology, sustainable energy, and medical devices, showcasing his diverse range of expertise and interests.

Career Highlights: With a career spanning over two decades, Johan Garssen has worked with leading research institutions and universities, constantly pushing the boundaries of technology and science. His inventions have revolutionized the way we approach challenges in healthcare, environmental sustainability, and beyond.

Collaborations: Throughout his career, Johan Garssen has collaborated with top companies, visionary inventors, and talented researchers to bring his ideas to life. His ability to work in multidisciplinary teams has led to the development of cutting-edge solutions that have a lasting impact on society.

Conclusion: Johan Garssen's passion for innovation, coupled with his dedication to creating a better world through technology, solidifies his position as a pioneering inventor in the global innovation landscape.

Profile summary based on public USPTO records.